|
|
|
|
P Savagner, AM Valles, J Jouanneau, KM Yamada and JP Thiery
Laboratoire de Physiopathologie du Developpement, Centre National de la Recherche Scientifique-Ecole Normale Superieure, Paris, France.
We described previously that acidic fibroblast growth factor (aFGF), but not basic fibroblast growth factor (bFGF), can induce the rat carcinoma cell line NBT-II to undergo a rapid and reversible transition from epithelial to mesenchymal phenotype (EMT). We now find that NBT-II EMT is stimulated by keratinocyte growth factor (KGF) in cells grown at low density. Accordingly, a high-affinity receptor showing 98% homology to mouse FGF receptor 2b/KGF receptor was cloned and sequenced from NBT- II cells. Northern analysis indicated that mRNA for FGF receptor 2b/KGF receptor was drastically down-regulated within 1 wk in aFGF-induced mesenchymal NBT-II cells. This decrease coincided with an up-regulation of FGF receptor 2c/Bek, a KGF-insensitive, alternatively spliced form of FGF receptor 2b/KGF receptor. Functional studies confirmed that KGF could not maintain EMT induction on mesenchymal NBT-II cells. FGF receptor 1 and FGF receptor 2c/Bek could also support EMT induction when transfected into NBT-II cells in response to aFGF or bFGF. Such transfected cells could bind bFGF as well as aFGF. Therefore, EMT can be induced through different FGF receptors, but EMT may also regulate FGF receptor expression itself.
This article has been cited by other articles:
![]() |
S. Oltean, B. S. Sorg, T. Albrecht, V. I. Bonano, R. M. Brazas, M. W. Dewhirst, and M. A. Garcia-Blanco Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity PNAS, September 19, 2006; 103(38): 14116 - 14121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Baraniak, J. R. Chen, and M. A. Garcia-Blanco Fox-2 Mediates Epithelial Cell-Specific Fibroblast Growth Factor Receptor 2 Exon Choice Mol. Cell. Biol., February 15, 2006; 26(4): 1209 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Steiling, M. Muhlbauer, F. Bataille, J. Scholmerich, S. Werner, and C. Hellerbrand Activated Hepatic Stellate Cells Express Keratinocyte Growth Factor in Chronic Liver Disease Am. J. Pathol., October 1, 2004; 165(4): 1233 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Billottet, N. Elkhatib, J.-P. Thiery, and J. Jouanneau Targets of Fibroblast Growth Factor 1 (FGF-1) and FGF-2 Signaling Involved in the Invasive and Tumorigenic Behavior of Carcinoma Cells Mol. Biol. Cell, October 1, 2004; 15(10): 4725 - 4734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakajima, R. Doi, E. Toyoda, S. Tsuji, M. Wada, M. Koizumi, S. S. Tulachan, D. Ito, K. Kami, T. Mori, et al. N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma Clin. Cancer Res., June 15, 2004; 10(12): 4125 - 4133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mareel and A. Leroy Clinical, Cellular, and Molecular Aspects of Cancer Invasion Physiol Rev, April 1, 2003; 83(2): 337 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. BAILLY, F. SOULET, D. LEROY, F. AMALRIC, and G. BOUCHE Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor FASEB J, February 1, 2000; 14(2): 333 - 344. [Abstract] [Full Text] |
||||
![]() |
M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of their E-Cadherin Expression J. Cell Biol., November 1, 1999; 147(3): 631 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanahashi, M. Suzuki, T. Imamura, and Y. Mitsui Identification of a 79-kDa Heparin-binding Fibroblast Growth Factor (FGF) Receptor in Rat Hepatocytes and Its Correlation with the Different Growth Responses to FGF-1 between Hepatocyte Subpopulations J. Biol. Chem., April 5, 1996; 271(14): 8221 - 8227. [Abstract] [Full Text] [PDF] |
||||